Compounds > cholest-4-en-3-one
Page last updated: 2024-08-26

cholest-4-en-3-one and Diarrhea

cholest-4-en-3-one has been researched along with Diarrhea in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Camilleri, M; Donato, LJ; Kenyon, SM; Lueke, A; Meeusen, JW1
Johnston, IM; Nolan, JD; Pruzanski, ME; Shapiro, DA; Vassie, C; Walters, JR1

Trials

1 trial(s) available for cholest-4-en-3-one and Diarrhea

ArticleYear
The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid.
    Alimentary pharmacology & therapeutics, 2015, Volume: 41, Issue:1

    Topics: Adult; Aged; Bile Acids and Salts; Chenodeoxycholic Acid; Cholestenones; Diarrhea; Female; Fibroblast Growth Factors; Humans; Ileum; Male; Middle Aged; Receptors, Cytoplasmic and Nuclear

2015

Other Studies

1 other study(ies) available for cholest-4-en-3-one and Diarrhea

ArticleYear
Description of analytical method and clinical utility of measuring serum 7-alpha-hydroxy-4-cholesten-3-one (7aC4) by mass spectrometry.
    Clinical biochemistry, 2018, Volume: 52

    Topics: Bile Acids and Salts; Cholestenones; Chromatography, Liquid; Constipation; Diarrhea; Feces; Humans; Mass Spectrometry; Sensitivity and Specificity; Serum; Steatorrhea; Tandem Mass Spectrometry

2018